Cheryl Guttman is a medical writer based in Deerfield, Ill.
Survey: Retina specialists see need for alternative treatments for macular edema associated with noninfectious uveitis
Survey respondents point to a perceived gap in treatments for uveitic macular edema, document interest in suprachoroidal drug delivery.
Unraveling burdens of X-linked retinitis pigmentosa
Recent literature review reveals dearth of data, highlights need for more research.
Addressing diabetic eye disease in senior patients
Confronting issues unique to aging may lead to better outcomes.
FDA approves XIPERE injection for treatment of uveitic macular edema
XIPERE, the first therapy utilizing the suprachoroidal space, demonstrates rapid efficacy, durable benefit, and favorable safety profile.
Ophthalmology Foundation zeroes in on mission
Organization looks to improve global eye care through ophthalmic education.
The state of retina therapeutics, dissected by international panel
Ophthalmologists face challenges of drug delivery for retinal diseases.
Dry AMD treatment facilitated by swept-source OCT imaging
Option detects treatment-naive nonexudative macular neovascularization in eyes with dry age-related macular degeneration.
Retina specialists may get ophthalmic formulation of bevacizumab
FDA will be asked to consider ONS-5010 for treating wet AMD.
Gaining a greater understanding of AMD
Why investigators are considering AMD to be a disease spectrum rather than a single disease.
Combining SD-OCT and UWF improves macular pathology detection
Dual imaging may reduce costs, unnecessary referrals, telehealth study results show.
Confirming uveitis treatment efficacy in study
Dexamethasone implant is key to treating non-infectious posterior segment uveitis
DME study: efficacy of intravitreal dexamethasone implant is robust
Eyes with chronic disease responded to steroid treatment
How ophthalmologists can benefit from en face OCT
Technology helps physicians understand normal and abnormal macular anatomy
Medication-induced retinal toxicity: How risk awareness can help
Key is to recognize usual patterns for systemic and topical medications
Inherited retinal disease: Gene therapy ushers new era
Ophthalmologist provides patient counseling pearls for selected retinal dystrophies
Shedding light on health care disparities among US patients
Study highlights role of demographic and socioeconomic characteristics in treatment
Pearls for optimizing patient outcomes of macular surgery
Specialist explains approaches for a variety of cases encountered during procedure
Pilot pregnancy pathway addresses challenges of diabetic retinopathy screening
The hope is that future analyses would show more patients completing the pathway and a lower rate of missed appointments.
DME strategies directed by knowledge of mechanisms
Insights into the pathophysiology of diabetic macular edema are providing a basis for therapeutic interventions.
What an intravitreal integrin antagonist may bring to DME
Multiple challenges remain for diabetic macular edema with unmet needs to improve treatment outcomes, speed of treatment benefit, and the duration of response.
Post hoc analysis: Protocol V provides more practical DME guidance for clinicians
Three risk-related baseline factors identified by this analysis may be associated with a potential need for injections.
Pandemic’s impact on US ophthalmology patient care: Real-world insights
Analyses of IRIS Registry data capture a snapshot of patient visits and receipt of anti-VEGF injections.
What a proposed biosimilar may mean for subfoveal wet AMD
Prospective randomized trial demonstrates clinical equivalence of biosimilar and reference ranibizumab
Research suggests course of diabetic eye disease influenced by genetic factors
A study including data from about 42,000 eyes found diabetic retinopathy (DR) severity is a risk factor for the progression of diabetic eye disease. Other findings support the idea that genetic factors influence the development of proliferative DR versus diabetic macular edema.
Identifying gaps in anti-VEGF treatment among minorities with DME
Study highlights the role of demographic and socioeconomic characteristics as contributors to disease- and treatment-related disparities among patients with diabetic macular edema.
KSI-301 for exudative retinal disease showing safety, efficacy, and durability
Phase 1b data show improved vision and reduced macular edema in patients, with only 3 loading doses and minimal re-treatments.
Exploring pathogenic cytokines as biomarkers for DME
Results support further research investigating transforming growth factor-β-Induced Gene Human Clone 30 (BIGH3).
Choosing a syringe for intravitreal injection
Manufacturers are stepping up to design products that will help maximize the safety and efficiency of intravitreal injection.
Aflibercept broadly effective for reducing DR severity in post-hoc analysis
The benefit is robust across a variety of demographics and baseline disease characteristics, according to data.
Researchers advocate for intraoperative intravitreal steroid during cataract surgery in DME eyes
Study offers a real-world scenario of a very specific, but frequent and crucial aspect of the care of patients with diabetes, suggests clinician
2 Clarke Drive Cranbury, NJ 08512